发明名称 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
摘要 Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, N-oxide, enantiomer, diastereomer, or tautomer thereof, or a racemic mixture comprising said enantiomer and/or diastereomer wherein: A and B are each independently C1-3 alkylene optionally substituted with 1 to 4 substituents selected from the group consisting of C1-3alkyl, C1-4alkoxy, carboxy, cyano, C1-3haloalkyl and halogen; D is N-R2; E is N, C or CR4Æ V1 is a bond, W is NR5, O, S, S(O), or S(O)2; or W is absent; Q is NR6, O, S, S(O) or S(O)2; X is N or CR7; Y is N or CR8; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is that the above compounds are modulators of glucose metabolism and are useful in the prophylaxis or treatment of metabolic disorders and complications thereof, such as, diabetes and obesity.
申请公布号 NZ544140(A) 申请公布日期 2009.10.30
申请号 NZ20040544140 申请日期 2004.07.09
申请人 ARENA PHARMACEUTICALS, INC. 发明人 JONES, ROBERT M;SEMPLE, GRAEME;XIONG, YIFENG;SHIN, YOUNG-JUN;REN, ALBERT S;CALDERON, IMELDA;CHOI, JIN SUN KAROLINE;FIORAVANTI, BEATRIZ;LEHMANN, JUERG;BRUCE, MARC A
分类号 C07D401/12;A61K31/4439;A61K31/505;A61K31/506;A61K31/513;A61K31/5377;A61P3/10;C07D239/52;C07D239/54;C07D401/14;C07D403/12;C07D405/14;C07D409/14;C07D413/14;C07D417/14 主分类号 C07D401/12
代理机构 代理人
主权项
地址
您可能感兴趣的专利